SeraCare Life Sciences Inc said it will be bought by an affiliate of private equity firm Linden Capital Partners for $80.8 million.The deal follows a trend set in 2011, when the U.S. healthcare industry witnessed a string of private equity takeovers as PE firms bet on rising use of services by an aging population in the United States, Europe and elsewhere.In October, PE firms Carlyle Group and Hellman & Friedman agreed to purchase Pharmaceutical Product Development for $3.9 billion and, in November, American Dental Partners was taken private by JLL Partners.The $4.00-per-share deal represents a premium of nearly 12 percent to SeraCare's Friday close on the Nasdaq. SeraCare had 20.2 million shares outstanding as of Feb. 3.
Shares of SRLS remained unchanged at $3.58. In the past year, the shares have traded as low as $2.58 and as high as $4.48. On average, 27024 shares of SRLS exchange hands on a given day and today's volume is recorded at 1934453.
Source
